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Abstract
Global gene expression profiling was performed using RNA from human embryonic neural stem cells (hENSC), and adult
human olfactory bulb-derived neural stem cells (OBNSCs), to define a gene expression pattern and signaling pathways that
are specific for each cell lineage. We have demonstrated large differences in the gene expression profile of human
embryonic NSC, and adult human OBNSCs, but less variability between parallel cultures. Transcripts of genes involved in
neural tube development and patterning (ALDH1A2, FOXA2), progenitor marker genes (LMX1a, ALDH1A1, SOX10),
proliferation of neural progenitors (WNT1 and WNT3a), neuroplastin (NPTN), POU3F1 (OCT6), neuroligin (NLGN4X), MEIS2,
and NPAS1 were up-regulated in both cell populations. By Gene Ontology, 325 out of 3875 investigated gene sets were
scientifically different. 41 out of the 307 investigated Cellular Component (CC) categories, 45 out of the 620 investigated
Molecular Function (MF) categories, and 239 out of the 2948 investigated Biological Process (BP) categories were significant.
KEGG Pathway Class Comparison had revealed that 75 out of 171 investigated gene sets passed the 0.005 significance
threshold. Levels of gene expression were explored in three signaling pathways, Notch, Wnt, and mTOR that are known to
be involved in NS cell fates determination. The transcriptional signature also deciphers the role of genes involved in
epigenetic modifications. SWI/SNF DNA chromatin remodeling complex family, including SMARCC1 and SMARCE1, were
found specifically up-regulated in our OBNSC but not in hENSC. Differences in gene expression profile of transcripts
controlling epigenetic modifications, and signaling pathways might indicate differences in the therapeutic potential of our
examined two cell populations in relation to in cell survival, proliferation, migration, and differentiation following
engraftments in different CNS insults.
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Introduction
Multipotent neural stem cells (NSC) that are capable of self-
renewal and generate all three cell types of the central nervous
system (neurons, oligodendrocytes, and astrocytes) are presently
the research hotspot in neuroscience. In the adult mammalian
brain, the subependymal layer of the lateral ventricles houses
neural stem cells giving rise to young neurons migrating towards
the olfactory bulb [1]. NSCs can be isolated from human fetal
brain tissue [1,2] as well as from several regions of the adult
human brain such as olfactory bulb (OB), cortex, hippocampus, or
subventricular zone (SVZ) of the lateral ventricles [3–10]. In
humans, a lateral ventricular extension of the migratory stream to
the OB has recently been demonstrated and neural stem/
progenitor cells (NS/PCs) have successfully been isolated from
the OB, which therefore represents an accessible source of neural
precursors [11–13]. Due to their ability to self-renew and to
differentiate towards the neuronal phenoype, human adult
olfactory bulb neural stem cells (OBNSCs) provide an attractive
tool for transplantation-based therapy of neurodegenerative
diseases that avoids the ethical issues raised by the use of human
embryos [14–23]. Even though adult OBNSC are lineage
restricted, which means that they can differentiate only into cells
of their tissue origin, there is a growing body of evidence that these
stem cells can break the barriers of germ layer commitment [23].
Although there is a great interest and potential of adult human
olfactory bulb NSC (OBNSC) in cell replacement therapy, there is
lack of data about their gene expression profiling, and molecular
pathways that govern their multipotency, proliferation, migration,
and signaling mechanisms. A better understanding of the
molecular basis of the aforementioned processes would facilitate
development of new therapeutic strategies for different neurode-
generative and traumatic diseases of the CNS.
Previous genomic profiling of human embryonic NSC found
expression of various genes related to stemness, multipotency, and
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e33542neuroectodermal cell fate [24,25]. Cai and colleagues found
expression of core neural stem cell markers, such as Nestin,
Prominin1, SOX1, and SOX2 [24]. Our group had previously
found that the set of genes expressed more highly in human
embryonic NSCs is enriched in molecules known or predicted to
be involved in M phase of mitotic cell cycle [26]. To our
knowledge, comparing the transcriptional profile of adult human
OB-NSC with other NSCs from embryonic, fetal, and adult tissue
is still lacking. Moreover, clarifying differences in expression
profile of genes known to control epigenetic alterations between
the two cell classes is crucial to provide insight about their future
therapeutic potential following engraftment. In this study, we focus
on comparing the genomic profiles and signal pathway analysis of
human adult olfactory bulb and embryonic NSCs using oligonu-
cleotide microarrays and immunocytochemistry to provide a).
knowledge of the gene expression profiles and alternative signaling
pathways of adult human OB-NSC, and whether adult human
OB-NSCs are identical to the embryonic ones; b). to determine
how the gene expression patterns of a adult OB-NSCs change and
whether its potency becomes narrowed in comparison to
embryonic ones, and c. to clarify possible epigenetic alteration
between the two cell classes. The gene expression profiling of adult
human OB-NSCs was also compared with different data sets from
other stem cell populations: a. a pluripotent stem cell derived from
the inner cell mass and hence without organ assignment (an ESC);
b. embryonic neural cells isolated and maintained primarily as
neurospheres; c. a multipotent stem cell from another organ
system (the human mesenchymal stem cells, hMSC); d. adult
human neuroprogenitor cells, and e. fetal human nuroprogenitor
cells.
Materials and Methods
Culturing of Human Embryonic NSCs
Five cell samples were selected for expression profiling as
indicated in Table S1. Cryopreserved human embryonic neural
stem cells were plated in a 6-well culture plate coated with
polyethyleneimine, and incubated at 37uC in a 5% CO2/95% air
incubator in serum-free DMEM/F-12 medium (Invitrogen,
Carlsbad, CA, USA) supplemented with a mixture of insulin–
transferrin–selenium (ITS) (Invitrogen, Carlsbad, CA, USA),
20 ng/ml recombinant human EGF (Invitrogen, Carlsband,
CA), 20 ng/ml recombinant human bFGF (Invitrogen, Carlsband,
CA), and 10 ng/ml recombinant human LIF (Invitrogen, Carls-
band, CA), according to the methods described previously [27]
.
The half of the medium was renewed every 4 days. Following
incubation for several months, the embryonic NSC in culture
continued to proliferate by forming free floating or loosely
attached growing spheres. For microarray analysis, nonpassage
embryonic NSC spheres were harvested, replated in a noncoated
6-well culture plate, and incubated further for 72 h in the NSC
medium without inclusion of 10% fetal bovine serum (FBS)
(Invitrogen, Carlsbad, CA, USA).
Isolation, and Culturing of Human Olfactory Bulb NSCs
The OBs were harvested from adult patients undergoing
craniotomy at the Institute of Neurosurgery, Catholic University,
Rome (Table S1). Informed consent was obtained according to
protocols approved by the Ethical Committee of the Catholic
University. Immediately after removal, the OBs were dissociated
in Papain 0.1% (Sigma-Aldrich, St. Louis, MO) for 30 minutes at
37uC. Dissociated cells were cultured in the presence of human
recombinant EGF (20 ng/ml; PeproTech, Rocky Hill, NJ), human
recombinant bFGF [10 ng/ml; PeproTech), and LIF (20 ng/ml;
Immunological Sciences, Rome, Italy) in DMEM/F12 (1:1)
serum-free medium (Invitrogen, Carlsband, CA) containing L
glutamine 2 mM, glucose 0.6%, putrescine 9.6 ug/ml, progester-
one 0.025 mg/ml, sodium selenite 5.2 ng/ml, insulin 0.025 mg/
ml, apo-transferrin sodium salt 0.1 mg/ml, sodium bicarbonate
3 mM, Hepes 5 mM, BSA 4 mg/ml, heparin 4 ug/ml. Primary
neurospheres were dissociated with Accutase (Invitrogen) for
4 minutes at 37uC, serially diluted and plated one cell per mini-
well onto 96-well plates. Mini-wells containing one single cell were
marked after microscopic confirmation and assessed for secondary
neurosphere generation after one week. Secondary neurospheres
were subsequently dissociated, plated at the density of 10
3 cells/
cm
2 in serum-free medium containing EGF and bFGF, and
passaged up to P30. Between P7 and P10, parallel cultures were
established in which cells were grown as adherent monolayers in
medium containing EGF and bFGF supplemented with 5% fetal
calf serum (Hyclone, Logan, UT). Cells were counted with
hemacytometer every 48 hours. Differentiation assays were
performed by 14 days after plating on Matrigel coated glass
coverslips in the absence of EGF and bFGF and in the presence of
1% fetal calf serum (Hyclone) supplemented with 39–59-cyclic
adenosine monophosphate (cAMP) 50 mM, all-trans retinoic acid
5 mM (Sigma Aldrich), and triiodothyronine (T3) 30 nM (Sigma
Aldrich) [28].
Illumina bead chip hybridizations and analysis of
expression data
Total cellular RNA was isolated from passage three embryonic
NSC (n=5), and passage twenty two adult human OB-NSCs
(n=6) using the Trizol (Invitrogen). Approximately 400 ng of total
RNA from each sample served as the input to generate
biotinlabeled cRNA using a linear amplification kit (Ambion,
Austin, TX, United States). RNA and biotinylated cRNA
concentrations were confirmed with Nanodrop ND-1000 and
controlled for quality using a BioRad Experion electrophoresis
station. Next, cRNA samples (750 ng) were hybridized onto
Illumina SentrixH HumanHT-12 v3 Expression Bead Chips at
58uC overnight [19 h]. Chips were scanned with the Illumina
Bead Array Reader (Factor = 1, PMT= 520, Filter = 100%),
and the numerical results were extracted with GenomeStudio
using the Gene Expression Module v.1.0.6. Raw data were
background-subtracted and normalized using the quantile nor-
malization method (lumi software package) [28,29]. Normalized
data were filtered for genes with significant expression levels
compared to negative control beads. Selection for differentially
expressed genes was performed on the basis of arbitrary thresholds
for fold changes plus statistical significance according to the
Illumina t-test error model (limma software) [30]. The mRNA
array data in MIAME compliant and has been submitted to the
NCBI Gene Expression Omnibus (GEO) database (Accession:
GSE35390).
Data Analysis
Gene Ontology Analysis. We identified gene ontology [GO]
groups of genes whose expression was differentially regulated
among the classes. By analyzing GO groups, rather than
individual genes, we were able to reduce the number of tests
conducted, and to enable findings among biologically related
genes to reinforce each other. This analysis is different than
annotating a gene list using GO categories. For each GO group we
computed the number n of genes represented on the microarray in
that group, and the statistical significance pi value for each gene i
in the group. These p values reflect differential expression among
classes and were computed based on random variance t-tests or F-
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summarize the p values for genes in the group; the Fisher (LS)
statistic and the Kolmogorov-Smirnov (KS) statistic as described in
[32]. Samples of n genes are randomly selected from genes
represented on the array and the summary statistic computed for
those random samples. The significance level associated with the
GO category is the proportion of the random samples giving as
large a value of the summary statistic as in the actual n genes of the
GO category. For each GO category, two significance levels are
computed, corresponding to the two summary statistics. We
considered a GO category significantly differentially regulated if
either significance level was less than 0.01. We considered all GO
categories with between 5 and 100 genes represented on the array.
Some of the categories were overlapping.
The evaluation of which Gene Ontology classes are differen-
tially expressed between pre and post treatment samples was
performed using a functional class scoring analysis [33]. For each
gene in a GO class, the p value for comparing pre versus post
treatment samples was computed. The set of p values for a class
was summarized by two summary statistics: (i) The LS summary is
the average log p values for the genes in that class and (ii)
the KS summary is the Kolmogorov-Smirnov statistic computed
on the p values for the genes in that class. The statistical
significance of the GO class containing n genes represented on the
array was evaluated by computing the empirical distribution of
these summary statistics in random samples of n genes. Functional
class scoring is a more powerful method of identifying differentially
expressed gene classes than the more common over-representation
analysis or annotation of gene lists based on individually analyzed
genes. The functional class scoring analysis for Gene Ontology
classes was performed using BRB-ArrayTools.
All significantly expressed transcripts (P#0.05, FC$1.5) were
clustered using a hierarchical clustering method. The determina-
tion of the correct number of clusters was based on measuring the
similarity of each gene to its own cluster compared to the similarity
of the gene to genes in other clusters, which was measured using
the average of the intracluster and intercluster distances.
MATLAB software (v. 7.3) was used for clustering and correlation.
Expander software (v. 5.07) [34] was used for the hierarchical
clustering of transcripts overexpressed in each stage separately and
cell cycle associated transcripts. Using the average linkage method,
transcripts were clustered, and the expression matrix was
visualized with a dendrogram. The STRING database (version
8.1) [35] was used to construct a regulatory network of
differentially expressed transcripts. The visualization of networks
was performed using Cytoscape (version 2.6.3) [36]. We used
BiNGO (a Cytoscape plugin) [37] to find statistically over- or
underrepresented Gene Onthology (GO) categories in the bi-
ological data as a tool to enrich the analysis of the transcriptome
dataset. Enrichment was determined in reference to all human
Entrez GeneIDs that were annotated in the Biological Process
branch [14,394 genes total]. P-values were derived from
a hypergeometric test followed by the Benjamini and Hochberg
false discovery rate [38]. A P-value cutoff of 0.01 was used to
identify significantly enriched categories. Pathway analyses were
assigned with the ClueGO (v. 1.2) plugin to all of the genes using
the KEGG database. A two sided hypergeometric test was used as
statistical test for the probability of each gene falling into
a pathway.
Functional Annotation and Molecular Network
Analysis. Functional annotation of significant genes identified
by microarray analysis was searched by the web-accessible
program named Database for Annotation, Visualization and
Integrated Discovery (DAVID) version 2009, National Institute of
Allergy and Infectious Diseases (NIAID), National Institutes of
Health (NIH) (david.abcc.ncifcrf.gov) [39,40]. DAVID covers
more than 40 annotation categories, including Gene Ontology
(GO) terms, protein–protein interactions, protein functional
domains, disease associations, biological pathways, sequence
general features, homologies, gene functional summaries, and
tissue expressions. By importing the list of the National Center for
Biotechnology Information (NCBI) Entrez Gene IDs, this program
creates the functional annotation chart, an annotation-term-
focused view that lists annotation terms and their associated
genes under study. To avoid excessive count of duplicated genes,
the Fisher’s exact test is calculated based on corresponding
DAVID gene IDs by which all redundancies in original IDs are
removed. Gene ontology (GO) and KEGG molecular pathway
analysis was performed to identify possible enrichment of genes
with specific biological themes using both the data set as a whole
and then in the individual K-means clusters. DAVID calculates
a modified Fishers Exact p-value to demonstrate GO or molecular
pathway enrichment, where p-values less than 0.05 after
Benjamini multiple test correction are considered to be strongly
enriched in the annotation category.
Strategy for selecting genes potentially involved in
motility, stemness, proliferation and migration. From the
results of microarray analysis, we sought to identify genes which
were of biological interest, i.e., which were directly relevant to the
basic mechanisms of NSC. Genomic databases (Gene) and
published work from the scientific literature (PubMed) were used
to select genes involved in: (1) motility and migration in
embryogenesis, with particular reference to neural stem cells; (2)
stemness and pluripotent capacity of NSCs; (3) cell proliferation
and/or migration in general.
Immunohistochemical validation of selected genes. For
immunocytochemistry, NPSs attached on poly-L-lysine-coated
cover glasses were fixed with 4% PFA in 0.1 M phosphate buffer,
pH 7.4 at room temperature (RT) for 5 min, followed by
incubation with phosphate-buffered saline (PBS) containing 0.5%
Triton X-100 at RT for 3 min. After blocking non-specific staining
by PBS containing 10% NGS, the cells were incubated in primary
antibodies. We used antibodies against nestin (Chemicon,
Temecula, CA), GFAP (Dako, Glostrup, Denmark), b-tubulin III
(Chemicon), neurofilament RT-97 (Developmental Studies
Hybridoma Bank, Iowa City, IA), MAP2 (Chemicon), NG2
(Chemicon), O4 (Chemicon), and hTERT (Novocastra
Laboratories). Then, they were incubated at RT for 30 min with
a mixture of FITIC-conjugated anti-rabbit IgG (Invitrogen) and
TRITIC-conjugated anti-mouse IgG (Invitrogen). After several
washes, they were examined on the Olympus BX51 universal
microscope. Immunostaining of NS/PCs was performed as
described
14.
Results and Discussion
Embryonic Human NSCs in Culture
Five specimens of human embryonic NSCs (hENSC) were used
in the current studies (Table S1). A single cell suspension of
hENSC were cultured in serum-free DMEM/F12 medium
supplemented with EGF and bFGF. The five specimens gave rise
to proliferating neurospheres, first appeared within 72 h of
primary culture and increased their numbers and diameters
quickly during 7 days after the onset of the culture. The
neurospheres were splitted into single cells using accatase.
Approximately 90% of the cells stained positive for the un-
differentiated NSC marker nestin, SOX2 and the proliferation
marker Ki67 (Figure 1A, B). Lack of Oct4 staining indicates that
Gene Expression Profile of OBNSC and hENSC
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multipotency of these human embryonic cell-derived NSC was
confirmed by differentiation assay in vitro. The differentiation
capacity of ENSC in differentiating conditions was revealed by
examining the types of molecular markers expressed by neurons
and glial cells. These cells could differentiate into, Dcx-positive
immature neurons (Figure 1C), GalC positive oligodendrocyte
(Figure 1D), and GFAP positive astrocyte (Figure 1E). The
hENSCs could be passed at least for ten generations by
mechanical dissociation and their stemness and multipotency
could be maintained in serum-free medium supplemented with
growth factors for at least one month.
Adult Human OB-NSCs in Culture
Dissociated adult human OB specimens were cultured in serum-
free medium supplemented with the mitogens EGF and bFGF.
Under these conditions, the OB cells generated primary neuro-
spheres with latencies that ranged from 6 to 8 weeks. Adult
Human OB-NSCs were capable of proliferating for several
months by forming free floating or loosely attached growing
spheres, when incubated in the NSC medium under the serum-
free culture conditions. When adult human OB-NSC spheres were
split into single cells with accutase and incubated in the NSC
medium supplemented with 10% FBS, they rapidly attached on
the plastic surface, and started to differentiate into the different
neuronal and glial lineage. To study the effects of culture time on
the differentiation potential of adult human OB-NSC, we studied
their differentiation potential during short (passage 9), and long
(passage 20)-term proliferation. Short term proliferated human
ON-NSC exhibited an intense immunoreactivity for GFAP
astrocytes marker (75%), MAP2 immature neuronal marker
(17.5%), and b-Tubulin mature neuronal marker (5%) (Fig. 2
A,B). In comparison, the differentiation potential of long-term
differentiated ones were 7564.9%, 12.562.4%, and 17.565.2%
for GFAP, MAP2, and b-Tubulin immunoreactivity respectively
(Fig. 3 A, B). None of the cells expressed the oligodendrocyte
marker O4 in short and long-term proliferation culture conditions
(data not shown). These results suggest that during short and long-
term culture conditions, the human OB-NSC were differentiated
into astrocytes (75%), immature (12.5–17%) and mature (5–
17.5%) neurons. Moreover, the neurogenic differentiation poten-
tial of human OB-NSC increased during long-term culture
conditions.
Human OBNSC Show Stable Gene Expression Over an
Extended Period of Time
In order to establish basal gene expression in our human
OBNSC, and begin to explore the differences between them and
human ENSC, the pattern of gene expression in our human
OBNSC was compared over time. Adult human OBNSC was
grown for 20 weeks in EGF and FGF containing media. Total
RNA was harvested at 5 and 25 weeks of culture (P9, and P 25),
and their gene expression profiles were compared using Illumina
Figure 1. Fluorescence image (20X) of GIBCOR hNSCs at
passage 3 that have been cultured in StemProR NSC SFM
and stained for the NSC phenotype markers nestin (green) and
the proliferation marker Ki67 (red, a). Cell nuclei were counter-
stained with DAPI (blue,a). Approximately 90% of the cells stain positive
for the undifferentiated NSC marker nestin and the proliferation marker
Ki67. Lack of Oct4 staining indicates that there are no remnant hESCs in
the culture (data not shown) (Invitrogen, Manual part no. A11592,
MAN0001758). Fluorescence images (20X) of GIBCOR hNSCs that have
been cultured in StemProR NSC SFM for three passages, and then
allowed to differentiate into neurons, oligodendrocytes, or astrocytes.
Upon directed differentiation, cells start to lose the undifferentiated
NSC marker, nestin, but stain positive for the differentiated cell type
markers Dcx, GalC, and GFAP. Cells were stained for the undifferentiated
NSC markers nestin (red, b) and SOX2 (green, c) prior to directed
differentiation. Cell were then differentiated into neurons and glial cells,
and respectively stained for the neuronal marker Dcx (green, c), for the
oligodendrocyte marker GalC (red, d), or for the astrocyte marker, GFAP
(green, e). The nuclei were counterstained with DAPI (blue) in panels B–
D (Invitrogen, Manual part no. A11592, MAN0001758).
doi:10.1371/journal.pone.0033542.g001
Figure 2. Differentiation potential of short-term proliferated
human OBNS cells. Fluorescent Phase contrast images of passage 9
human OBNS immunostained for the GFAP astrocytes marker, MAP2
immature neuronal marker, and b-Tubulin mature neuronal marker.
Scale bar, 100 mm. The nuclei were stained blue with DAPI. The plot
shows the percentage of positive GFAP astrocytes, MAP2 immature,
and b-Tubulin mature neurons, generated by each cell type.
doi:10.1371/journal.pone.0033542.g002
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analyze the relative abundance of each gene. The total gene
expression levels in human OBNSC (Table S2) were stable for
approximately 25 weeks in the long-term presence of EGF and
FGF. The gene array set contains 47232 expressed genes and
expressed sequence tags (ESTs). Only 94 genes were differentially
expressed between our two examined cellular classes, OBNSC Vs.
hENSC (Table S3) which were nearly equal to the number of false
positive signals. These finding might indicate that there was no
significant differences in the gene expression profiles of our
examined cell population over prolonged period of culture, and
that OBNSCs were genetically stable during our examined time
scale.
Next, we examined genes that are important in the development
of the nervous system. As expected, nestin, notch, and the EGF
receptor were up-regulated in both cell populations. Several genes
identified as stem-cell specific including Slit2, and insulin-like
growth factor binding protein 2 was also present in OBNSC.
Members of bone morphogenetic protein (BMP) family which is
involved in epidermal induction [41] and glial fate [42], genes for
growth factors such as brain-derived neurotrophic factor (BDNF),
glial derived neurotrophic factor (GDNF), FGF-2 and its receptor
FGFR1, FGF-8, and about 22 members of wnt family are
identified in our OBNSC. The full list of up and down regulated
genes across the five human OBNSC replicates can be found in
Table S4.
Transcriptome Analysis of Human Embryonic NSC versus
Human Adult OB-NSC
Hierarchical clustering dendrogram of relative gene expression
in different populations of OBNSC and human ENSC was
generated using the GeneSpring GX Software. hENSCs clustered
together and are distinguished from human OBNSC cells. There
was no correlation between hENSC and adult human OBNS cells
samples. But there was a strong correlation between the arrays
from the same samples. Unsupervised hierarchical clustering based
on overall gene expression profiles reveals two distinct clusters
corresponding to the two cell groups. This suggests that the
samples from the two cell types (hENSC vs OBNSC cells) do
indeed represent two statistically distinct populations suitable for
valid comparison (Fig. 4 A, B). An analysis of transcriptome
dynamics between hENSC and OBNSC revealed that 1252
transcripts were modulated between the two cell populations
(Table S5). While most 83% (1049) of the modulated genes were
up-regulated in hENSC, only 17% (203) of modulated genes were
up-regulated in OBNSC.
Up-regulated Genes in Both Human ENSC and OBNSC
Transcripts of genes involved in neural tube development and
patterning (ALDH1A2, FOXA2), progenitor marker genes
(LMX1a, ALDH1A1, SOX10), proliferation of neural progenitors
(WNT1 and WNT3a), neuroplastin (NPTN), POU3F1 (OCT6),
neuroligin (NLGN4X), MEIS2, and NPAS1 were up-regulated in
both OBNSC and hENSC. Neuroplastin NPTN is a glycoprotein
that belongs to the immunoglobulin superfamily of cell adhesion
molecules (CAMs). This gene is also involved in the long-term
potentiation of hippocampal excitatory synapses through the
activation of p38MAPK [43]. Recently, it was demonstrated that
neuroplastin binds to and activates fibroblast growth factor
receptor 1 (FGFR1) [44], and it may have a function in FGF
signaling in OBNSC and hESCs. Some antagonists of FGF
signaling, such as SPRY1, were also overrepresented in OBNSC
and hESCs. SPRY1 is involved in cortical neuron pattern
formation and inhibits caudal cell fates [45]; its role in human
embryonic stem cells (hESCs) with a high concentration of FGF is
not clear and may be important for the fine tuning of FGF
signaling in ESCs. POU3F1 is a member of the pou domain family
of proteins and is involved in neural ectoderm formation; its
expression is down regulated upon ESC differentiation and
increases again during brain development [46]. NLGN4X is
a putative neuronal cell surface protein involved in cell-cell-
interactions and may be involved in the formation and remodeling
of central nervous system synapses [47]. During the early
development of neural cells, the MEIS2 homeobox genes can
positively control PAX6 transcription and induce hESCs toward
neutralization [48]. The protein encoded by the NPAS1 gene is
a member of the basic helix-loop-helix (bHLH)-PAS family of
transcription factors and is specifically expressed in neural tissue.
NPAS1 in mice modulates the transcription of erythropoietin by
binding to its enhancer region in vivo; thus, it indirectly controls
oxygen responsive elements during late embryogenesis and central
nervous system development [49].
Other genes that were up-regulated in our OBNSC and
hENSCs are CYP26A1, CPZ, and FGF8. CYP26A1 plays a key
role in retinoic acid (RA) metabolism, highlighting the importance
of the retinoic acid (RA) metabolic pathway in the neural initiation
stage [50]. CPZ, modulates the WNT signaling pathway by
cleaving some undefined protein or by binding to the WNT
molecule [51]. FGF8 a paracrine factor that is downregulated as
differentiation progresses, and has a function during dopaminergic
neuron specification and proliferation [52]; it works cooperatively
with SHH in the specification of midbrain neurons. Shh protein
can induce Foxa2 and ventralize neural progenitors and, in
a positive regulatory loop, FOXA2 can induce endogenous SHH
and inhibit NKX2.2 [53] and also the serotonergic phenotype.
Endogenous transcription of FGF8 resulting from RA exposure
[54] can induce WNT1 expression that cooperatively with FGF8
can induce neural progenitors to differentiate into TH-producing
cells. Matrix associated genes, including MMP1, THBS1, and
ITGB1BP3, were also among our OBNSC, and hESC enriched
genes, suggesting that expression of these genes provides an
environment conducive to the proliferation of stem cells. As
expected, major markers of pluripotent hES cells, including
NANOG, OCT4 (POU5F1), REX1 (ZFP42), FGF4, FOXD3,
Figure 3. Differentiation potential of long-term proliferated
human OBNS cells. Fluorescent Phase contrast images of 20 human
OBNS immunostained for the GFAP astrocytes marker, MAP2 immature
neuronal marker, and b-Tubulin mature neuronal marker. Scale bar,
100 mm. The nuclei were stained blue with DAPI. The plot shows the
percentage of positive GFAP astrocytes, MAP2 immature, and b-Tubulin
mature neurons, generated by each cell type.
doi:10.1371/journal.pone.0033542.g003
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NPCs and MPCs. Both cell types overexpressed other genes
commonly associated with a neural stem/progenitor cell fate:
Jagged 1 (JAG1) [55], SOX2 [56], SOX4 [57], Nestin (NES) [58],
the oligodendrocyte lineage transcription factor two [OLIG2]
[59], the G protein-coupled receptor 56 (GPR56) [60], the
vascular endothelial growth factor (VEGF), and the stem cell
marker Musashi1 (MSl1) [60]. Genes associated with cell cycle
progression, such as a disintegrin and metalloproteinase domain
nine (ADAM9), HAT1-, protein kinase-, DNA-activated, catalytic
polypeptide (PRKDC), or RNA binding motif protein 3 (RBM3)
were up-regulated in both cell types.
Genes Specific for Adult OB-NSC
The up-regulation of 203 genes and the down-regulation of
1049 in our OBNSC in comparison to hENSC might point to
peculiar alternative metabolic pathways for each cell class. We
found that a number of genes specific for neurons were transcribed
only on reduced levels: the 25-kDa synaptosome-associated
protein (SNAP25), neurogranin (NRGN), and others. When
looking for genes specifically expressed in our OBNSCs, a large
number of such genes can be retrieved. The low-affinity nerve
growth factor receptor precursor (p75, NGFR), Nestin (NES), and
chondroitin sulfate proteoglycan four (CSPG4) were specifically
highly expressed in the OBNSC (Table S4). The gene CSPG4
encodes for the epitope NG2, which is reported to be specifically
expressed on oligodendrocyte precursor cells. Genes associated
with cell cycle progression, such as a disintegrin and metallopro-
teinase ndomain nine (ADAM9), HAT1-, protein kinase-, DNA-
activated, catalytic polypeptide (PRKDC), or RNA binding motif
protein 3 (RBM3) were up regulated in OBNSC but not in
hENSC.
The expression pattern of OBNSs lacked the mRNA for myelin
components of mature oligodendrocytes: myelin basic protein
(MBP), proteolipid protein one (PLP1), and others. The neurofila-
ment heavy chain (NEFH) or the GABAreceptor, alpha 1
(GABRA1) were upregulated (Table S4). A number of SOX-
and homeobox genes were highly expressed: SOX4, SOX11,
SOX12, and the LIM homeobox gene two (LHX2), or the distal-
less homeobox gene 2 (DLX2). In addition, we could detect an up-
regulation of prominin one (PROM1 or CD133) in OBNSC. Cell
proliferation-like topoisomerase II-(TOP2A) genes were uniquely
overexpressed in OBNSC.
The a-receptor of platelet derived growth factor (PDGFRa) was
expressed in OBNSC only. As reported earlier, even fetal hNPCs
showed a high expression of PDGFRa absent both [61]. As
Figure 4. Hierarchical clustering and interclass correlations between hESCs and OBNSCs. A. Hierarchical clustering of 1252 differentially
expressed genes was performed using the mean signal intensity for each replicate. Biological replicates of hESCs and OBNSCs were compared and
showed high intraclass correlations compared with interclass correlations. Two distinct clusters were distinguishable based on the expression
patterns of the different cell types. The differentially expressed transcripts were clustered into two expression groups, including 203 genes that were
up regulated in OBNSC compared to 1049 genes that were up regulated in hENSC. B. Expression patterns of representative genes from different
expression clusters. Transcripts that are highly up-regulated in hENSC (red) compared with the OBNSC (green).
doi:10.1371/journal.pone.0033542.g004
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ation and migration of cells [62], this may indicate a pivotal role in
stem cell recruitment and hence the expression of its receptor on
stems cells in general. PDGFRa-signaling occurs early in the adult
stem cell lineage and may help regulate the balance between
oligodendrocyte and neuron production [63].
Comparative Transcriptome Analysis of Human hENSC
and OBNSC
We then compared the complex transcriptomes of hENSCs
with adult human OBNSCs. Global comparison between hENSCs
and OBNSCs however showed that both NSC types differ in
various gene categories, with the largest differences in ‘‘macro-
molecular complex assembly (10 genes), macromolecular complex
subunit organization (10 genes), cellular macromolecular complex
assembly (6 genes), cellular macromolecular complex subunit
organization (6 genes), protein complex assembly (7 genes), protein
complex biogenesis (7 genes), ribonucleoprotein (19 genes),
cytosolic ribosome (13 genes), ribosomal protein (16 genes),
translational elongation (13 genes), protein biosynthesis (13 genes),
with an enrichment score of 6.78 (Table S5). Despite these global
differences between the transcriptomes of hENSCs and OBNSCs,
major similarities could be observed (Table 1, and Table S5): Most
of these similarities are based on genes being related to neuronal
and neuroendocrine function, signaling cell membrane and
extracellular matrix (Table 1, and Table S5): Brain and acute
leukemia gene (BAALC), normally expressed in brain by neurons
and endocrine cells [64] and highly conserved among mammals
[65], glycoprotein 6B (GPM6B), endothelian receptor A
(EDNRA), and Stathmin-like 2 (SCGN10) were as well highly
expressed in hENSCs and OBNSCs. Genes involved in fat
metabolism such as apolipoprotein D were also up-regulated in
hENSCs and OBNSCs. The SLC6A15 (solute carrier family 6,
member 15) and S100 calcium binding protein B, NeuroD1 and
OTX1 were highly expressed in both cell types. However,
previous cell biology investigations including differentiation studies
of hmNSCs demonstrated all major properties of NSCs including
differentiation into functional glia and neurons [66–68], while they
lost their mesodermal stromal cell characteristics [66]. Notewor-
thy, we previously found extensive differences of transcriptomes
even between various ‘‘primary’’ NSC types including particularly
the expression of stem cell markers suggesting divergent paths to
maintain the neuroprogenitor cell state [61].
To further confirm our results, we compared the global genomic
profiling of our data with several other data sets from adult neuro
progenitor cell (aNPCs), fetal neuro progenitor cell (fNPCs),
human mesenchymal stem cells (hMSCs), and adult hippocampal
tissue (aHypp). Genes that were up-regulated in both human
OBNSC and hENSC include various genes related to differenti-
ated neurons and glia, such as MAPT [microtubule associated
protein tau] and other tubulin associated genes, synapse formation
(SNAP25), and axon guidance (ROBO-SLIT) molecules (Table
S3). We have observed up-regulation of stem cell markers such as
NES, PROM1, SPRY1, CXCL12, CXCR4. We also observed
up-regulation of axon guidance cues and neurotrophins, including
ROBO2 and ROBO3 and their receptors SLIT2 and SLIT3, Eph
receptors (EFNB3, EPHA3, EPHA5, EPHA8, EPHB1, EPHB3)
and their ligands, and semaphorin receptors (SEMA3E, SEMA4F,
SEMA5B, SEMA6C). The protachykinin gene (TAC1), tyrosine
hydroxylase (TH) and the somatostatin gene (SST) were also
among the highly expressed transcripts in OBNSC (Table S4).
We also compared the expression profile of our OBNSC with
hMSCs as a multipotent adult stem cell. We found that hMSCs
overexpress a number of genes commonly found in connective
tissues (decorin (DCN), fibronectin (FN1), and various collagen
proteins), similar to peripheral nervous system (PNS) tissues.
However, there are various genes expressed by both OBNSCs and
hMSCs, mainly extracellular matrix proteins (COL1A1, CO-
L1A2, COL3A1, LOXL2) and genes such as insulin-like growth-
factor 3 and 5 (IGFBP3 and IGFBP5) (Table S4). Other
extracellular matrix components genes namely laminin-4 (LA-
MA4), tenascin C (TNC), and integrin-alpha7 (ITGA7) were also
up-regulated in OBNSC (Table S4).
Functional Annotation Clustering of OBNSC and hENSC
Functional annotation of significant genes identified by micro-
array analysis was searched by the web-accessible program named
Database for Annotation, Visualization and Integrated Discovery
(DAVID) version 2009. Clustering for the top 200 up-regulated
genes (Log2 176-3.1) of human OBNSC using DAVID, we
identified 28 annotation clusters. The annotation cluster 1 (Table
S6) showed the highest enrichment score of 1.76 and included
genes related to macromolecular complex assembly (10 genes),
macromolecular complex subunit organization (10 genes), cellular
macromolecular complex assembly (6 genes), cellular macromo-
lecular complex subunit organization (6 genes), protein complex
assembly (7 genes), protein complex biogenesis (7 genes).
Functional Annotation Clustering using DAVID for the top 200
up-regulated genes of human ENSC identified 61 annotation
clusters. The annotation cluster 1 included genes related to
ribonucleoprotein (19 genes), cytosolic ribosome (13 genes),
ribosomal protein (16 genes), translational elongation (13 genes),
protein biosynthesis (13 genes), with an enrichment score of 6.78
(Table S7).
GO Class Comparison
The categorization of the genes by gene ontology terms were
similar in both NPC populations (Fig. S2), whereas the genes
themselves overlapped only occasionally [refer to supplemental.
By Gene Ontology: 325 (Figure 5) out of 3875 investigated gene
sets passed the 0.005 significance threshold. LS/KS permutation
test found 125 significant gene sets. Efron-Tibshirani’s maxmean
test found 240 significant gene sets between adult OBNSC, and
hENSC (under 200 permutations). 41 out of the 307 investigated
Cellular Component (CC) categories were significant. 45 out of the
620 investigated Molecular Function (MF) categories were
significant. 239 out of the 2948 investigated Biological Process
(BP) categories were significant [Table S8].
KEGG Pathway Class Comparison
75 out of 171 investigated gene sets passed the 0.005
significance threshold. LS/KS permutation test found 72 signif-
icant gene sets between adult OBNSC and hENSC. Efron-
Tibshirani’s maxmean test found 17 significant gene sets (under
200 permutations) (Table S9).
Epigenetic Modification Signatures
The transcriptional signature also deciphers the role of another
type of developmental regulation that concerns genes involved in
epigenetic modifications. Among genes that are differentially
expressed during neural or mesoderm differentiation, genes
encoding helicases that function to open chromatin to enhance
transcription in the SWI/SNF DNA chromatin remodeling
complex family, including SMARCC1 and SMARCE1, were
found specifically up-regulated in our OBNSC but not in hENSC
and may interact with proteins encoded by other specific genes
such as ARID2 and ARID1B [69,70]. These proteins may play
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with global and local changes in chromatin structure [71].
Dnmt3b is found to be up-regulated in our OBNSC but not in
hENSC (Table S4). Dnmt3b are expressed highly in the
developing mouse embryo and are responsible for
global de novo methylation after implantation [72], consistent with
the finding that Dnmt3a can carry out de novo methylation in
transgenic flies [73]. Dnmt3L, a protein that by itself has no
DNMT activity, colocalizes with Dnmt3a and Dnmt3b and is
essential for establishing methylation imprints in the female germ
line [74,75]. Last, the deletion of Dnmt2, a member of the DNMT
family that lacks biochemically detectable methyltransferase
activity, has no obvious phenotype in mice [76]; however, this
gene is conserved in Drosophila, highly expressed during oogenesis
and may be responsible for the small amount of non-CpG
methylation seen in the fly embryo [77,78]. In general, the known
developmental effects of DNA methylation on gene expression
involve long-term silencing of gene expression. The attractive idea
that genes are transcriptionally activated by removing DNA
methylation has lacked strong experimental support until recently.
Many correlations between expression and loss of DNA methyl-
ation have been reported, and the methylation of some reporters
has been shown to inhibit expression. A notable recent example is
the human maspin gene, the promoter of which is unmethylated in
Figure 5. Expression patterns of representative genes from different GO clusters of OBNSC (class 1) and human ENSC (Class 2).
doi:10.1371/journal.pone.0033542.g005
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thought to be one of the most important risk factors for cancer, an
age-related predisposition to the hypermethylation of CpG islands
that can silence tumor suppressor genes [80] 129 may be one of
the factors that could increase the risk of developing of
malignancies in some individuals [81,82,83].
Alternative Signaling Pathways Controlling Cell Fate
Decisions
Levels of gene expression were explored in 3 signaling
pathways, Notch, Wnt, and mTOR signaling pathway that are
known to be involved in NS cell fates determination but required
different partners depending of lineage-specific differentiation.
Notch signaling pathway. About 25 genes encoding for
ligands of Notch, such as PSEN2, NUMB, NOTCH4, NOTCH3,
NOTCH2, NOTCH1, NCOR2, LFNG, KAT2A, JAG1, HES5,
HDAC2, HDACI, EP300, DVL3, DVL2, DTX3, DTX2, DLL3,
DLL1, CTR1, APH1A AND ADAM17, were found to be up-
regulatedinthehENSCbutnotinOBNSc(FigureS1,S2,TableS9].
Regarding the receptors in this pathway,
NOTCH1, NOTCH2, NOTCH3, and NOTCH4 were
specifically up-regulated in hENSC, and were found down-
regulated in OBNSC. Genes implicated in the modulation of the
activity of NOTCH signaling that were specifically up-regulated in
hENSCs included LFNG (encoded a fucose-specific
glycosyltransferase), ADAM17 (encoded a metallopeptidase
involved in the proteolytic release of Notch intracellular domain
fromtheNotch1receptor),andPSEN1(presenilins-1)involvedinthe
cleavageoftheNotchreceptorandtheregulationofgammasecretase
activity.NUMBencodingforaninhibitoroftheNotchpathwayand
playing a role in the determination of cell fates during development
was specifically up-regulated in hENSCs. At least, specific
transcriptional factors HES1, downtream targets of Notch
signaling, were found specifically up-regulated in OBNSCS but not
in hENSC, whereas HES5 was up-regulated in hENSC only.
Inhibition of NOTCH can disrupt the maintenance of stem cell
characteristicsofNPCs[84,85],bysuppressingtheHES1andHES5
genes,whichnegativelycontroltheexpressionoftheproneuralgenes
MASH1 and NGN1 [86,87,88]. As shown previously, NOTCH
signalingnegativelycontrolsneurogenesisinastepwiseprocess;inthe
firststep,itsactivationleadstogliogenesisasopposedtoneurogenesis,
and in the second step, its activation promotes the production of
astrocytesandinhibitstheproductionofoligodendrocytesandneural
fates [89]. NOTCH signaling in neural system development has
multiple functions. Not only can NOTCH switch a neural cell fate
decision[90],butNOTCHsignalingalsoplaysanimportantrolein
the maintenance of neural stem cells [91]. NOTCH molecules are
alsoneededforcellfatedeterminationinhESCsastheydifferentiate
into the threegerm layers[92].
Wnt signaling pathway. Concerning the 269 genes involved
in the Wnt signaling pathway, up-regulation of 94 genes encoding
receptors, legends, and other regulators of this canonical pathway
was observed in hENSC, whereas only 24 genes were up-regulated
in OBNSC (Figure S3, 4, Table S4). Wnt inhibitors, including
secreted antagonists such as DKK1 was up-regulated in hENSC,
and down regulated in OBNSC. The expression of WNT1 and
most WNT receptors was down-regulated in hENSC, although the
expression of WNT8A, WNT9A, WNT7A, WNT5B and WNT2
increased in OBNSC (Table S9). Both cell populations had some
overlap in the expression patterns of WNT pathway molecules.
The DKK1 gene, an inhibitor of WNT signaling, was up-
regulated in hENSCs but not in OBNSCs. However, another
inhibitor, DKK2, had an increased expression level in OBNSCs
but not in hENSC. Other Wnt inhibitor such as SFRP2 was
overexpressed specifically in OBNSCs. In addition, genes
encoding for Wnt ligands such as WNT2B, reported to be
a repressor of the canonical pathway, appeared to be specifically
up-regulated in OBNSC, whereas WNT5A, noncanonical ligand,
was found to be up-regulated in hENSC, WNT5B was up-
regulated in OBNSC. For the Wnt Receptors, notably Frizzled
proteins, FZD, FZD2, 3,4,6,9, were found, respectively, up-
regulated or not regulated in hENSCs and OBNSCs. These
findings may explain how different members of the WNT gene
family may control differentiation of different cell types.
Concerning transcriptional regulators involved downstream of
Wnt signaling pathways, genes involved in the repression of the b-
catenin complex such as SOX transcription factor (SOX3) was
down regulated in both cell population. CTNNBIP1, a gene
encoding a small soluble inhibitory protein also termed ICAT
(inhibitory of beta-catenin and TCF), which prevents the in-
teraction of b-catenin with different binding partners; including
LEF1 was specifically up-regulated in OBNSCs (Table S4).
Gene encoding for the transcription repressor TLE4, a member
of the Groucho family, was down regulated in our both cell
populations. The expression of genes known to be controlled
directly downstream of the canonical b-catenin pathways, some
genes, such as DCT was down regulated in both cell types, others
genes such as POU3F2, and NRCAM, controlled downstream of
the complex containing LEF1, were down regulated in hENSC
but not in OBNSCs. Blocking canonical Wnt signaling during
post-implantation development increased the
number of neural precursors which failed to differentiate to
mature neurons, and produced defects of embryonic axis
elongation, neurulation and neural tube closure that phenocopy
the b-catenin null embryo [93].
mTOR signaling pathway. Of the 95 transcripts associated
with mTOR signaling pathway, 42 genes were up-regulated in our
hENSC, and only 5 transcripts were up regulated in OBNSC.
Whereas VEGFB, ULK1, STRADA, RPS6KB2, RPS6,
RPKAA1, PIK3R2, MAPK2, and AKT1 were up-regulated in
hENSCs, RPS6KB2, RPS6KA3, MLST8, MAPK1, and EIF4E2
were up-regulated in OBNSCs (Figure S5, S6, Table S9]. In
embryonic stem cells (ESCs), mTOR signaling can stabilize
OCT4, SOX2 and NANOG expression and can negatively
control the induction of endoderm and mesoderm from ESCs.
Inhibition of mTOR with rapamycin enhanced the expression of
endoderm and mesoderm markers and impaired the pluripotency
of hESCs, but this effect was not observed in neural differentiation
[94]. mTOR signaling functions in neural induction and is
involved in the EGF/FGF2-mediated maintenance of neural stem/
progenitor cells. Phosphorylated mTOR has been up-regulated in
a PI3K-Akt dependent manner during NPC differentiation
induced by insulin [95].
Cell cycle pathway. Gene expression analysis of 200
transcripts of cell cycle signaling molecules revealed the up-
regulation of 113 transcripts in our hENSC, and only 11
transcripts in OBNSC. CDK2, CDK4, CDK6 and molecules
involved in the G2-S phase transition, including CDC2, CDC25C
and MAD2L1, have higher expression levels in hENSC compared
to OBNSCs. TFDP1, another transcription factor that binds to
EF1 and controls the transcription of EF1 target genes [95], is also
up-regulated in our hENSCs but not in OBNSCs (Figure S7, S8,
Table S9).
In conclusions, we have demonstrated large differences in the
gene expression profile of human embryonic NSC, and adult
human OBNSCs, but less variability between parallel cultures.
Transcripts of genes involved in neural tube development and
patterning, progenitor marker genes, proliferation of neural
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By Gene Ontology, 325 out of 3875 investigated gene sets were
scientifically different between both cell populations. KEGG
Pathway Class Comparison had revealed that 75 out of 171
investigated gene sets were significantly different between the two
cell populations. The transcriptional signature also deciphers the
role of genes involved in epigenetic modifications. In conclusion,
the differences in gene expression of transcripts controlling
epigenetic modifications, and signaling pathways might indicate
differences in the therapeutic potential of OBNSCs Vs. hENSCs.
Supporting Information
Figure S1 Notch signaling pathway. About 25 genes
encoding for ligands of Notch were found to be up-regulated in
the hENSC but not in OBNSc. The network was generated by
‘‘find significant pathway’’ function in GeneSpring GX v11
(p,0.05). Connections were based on known interactions between
these proteins within the Reactome database. The biological
relationship between two proteins is represented as a line.
(TIF)
Figure S2 Heat map of the Notch signaling pathway
forming genes in OBNSC Vs. hENSC.
(TIF)
Figure S3 Wnt signaling pathway. Up-regulation of 94 genes
related to this pathway encoding receptors, legends, and other
regulators of this canonical pathway was observed in hENSC,
whereas only 24 genes were up-regulated in OBNSC.
(TIF)
Figure S4 Heat map of the Wnt signaling pathway
forming genes in OBNSC Vs. hENSC.
(TIF)
Figure S5 mTOR signaling pathway. Of the 95 transcripts
associated with mTOR signaling pathway, 42 genes were up-
regulated in our hENSC, and only 5 transcripts were up regulated
in OBNSC.
(TIF)
Figure S6 Heat map of the mTOR signaling pathway
forming genes in OBNSC Vs. hENSC.
(TIF)
Figure S7 Cell cycle signaling pathway. Gene expression
analysis of 200 transcripts of cell cycle signaling molecules revealed
the up-regulation of 113 transcripts in hENSC, and only 11
transcripts in OBNSC.
(TIF)
Figure S8 Heat map of the cell cycle signaling pathway
forming genes in OBNSC Vs. hENSC.
(TIF)
Table S1 Details of Embryonic and adult NSC samples used in
the current study.
(DOC)
Table S2 Normalized microarray data of 47232 Illumina probe
sets demonstrating the gene expression profile of adult human
olfactory bulb neural stem cells (OBNSCs).
(XLS)
Table S3 Genes which are differentially expressed among adult
human OBNSCs (class 1), and human embryonic NSCs (class 2).
(XLS)
Table S4 Normalized microarray data of 47232 Illumina probe
sets demonstrating the gene expression profile of adult human
olfactory bulb NSCs (OBNSCs), and human embryonic NSCs.
(XLSX)
Table S5 1250 modulated genes between human OBNSCs, and
hENSC, 203 were up-regulated in OBNSC, and 1049 were up-
regulated in hENSC.
(XLSX)
Table S6 Functional Annotation Clustering using DAVID for
203 unregulated genes of human hENSC. 61 annotation clusters
were obtained. The annotation cluster 1 included genes related to
ribonucleoprotein (19 genes), cytosolic ribosome (13 genes),
ribosomal protein (16 genes), translational elongation (13 genes),
protein biosynthesis (13 genes), with an enrichment score of 6.78.
(TIF)
Table S7 Functional Annotation Clustering using DAVID for
203 unregulated genes (Log2#5–12) of human OBNSC. 28
annotation clusters were obtained. The annotation cluster one
included genes related to macromolecular complex assembly
(10 genes), macromolecular complex subunit organization (10
genes), cellular macromolecular complex assembly (6 genes),
cellular macromolecular complex subunit organization (6 genes),
protein complex assembly (7 genes), and protein complex
biogenesis (7 genes) with an enrichment score of 27.56.
(TIF)
Table S8 Gene Ontology of differentially expressed transcripts
in OBNSCs and hENSC. 25 out of 3875 investigated gene sets
passed the 0.005 significance threshold LS/KS permutation test
found 125 significant gene sets. Efron-Tibshirani’s maxmean test
found 240 significant gene sets (under 200 permutations). By Gene
Ontologies: 41 out of the 307 investigated Cellular Component
(CC) categories are significant. 45 out of the 620 investigated
Molecular Function (MF) categories are significant. 239 out of the
2948 investigated Biological Process (BP) categories are significant.
(HTML)
Table S9 KEGG Pathway of differentially expressed transcripts
between OBNSCs and hENSCs. 75 out of 171 investigated gene
sets passed the 0.005 significance threshold LS/KS permutation
test found 72 significant gene sets. Efron-Tibshirani’s maxmean
test found 17 significant gene sets (under 200 permutations).
(HTML)
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